Objective. Interstitial lung disease (ILD), especially rapidly progressive ILD (RPILD), is a
major poor prognostic factor in patients with DM. We investigated the association of anti-…

Background Interstitial lung disease (ILD) associated with clinically amyopathic
dermatomyositis (CADM) is a potentially fatal condition in which the clinical features are not well …

Background Pirfenidone is a novel anti-fibrotic and anti-inflammatory agent that inhibits the
progression of fibrosis in animal models and in patients with idiopathic pulmonary fibrosis (…

Several mutations in the surfactant protein C (SP-C) gene (SFTPC) have been reported as
causing familial pulmonary fibrosis (FPF). However, the genetic background and clinical …

Background: Lung cancer is the most common neoplasm in Turkey, but there is not enough
data on the characteristics of this mortal illness in our country. Objectives and Methods: The …

Objective. We have tried to clarify the clinical importance of the measurement of serum type-I
interferon (IFN) in patients with anti-melanoma differentiation-associated gene 5 Ab (MDA5 …

Background Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is associated with
high mortality. However, few studies have so far reviewed analyses of autopsy findings in …

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive
fibrosing interstitial pneumonia of unknown cause, and the prognosis remains poor. On the …

A 68-year-old man, who was a patient with established rheumatoid arthritis (RA) with RA-associated
interstitial lung disease (RA-ILD) and pulmonary emphysema, began taking …

Background Acute exacerbations of idiopathic pulmonary fibrosis are major causes of
morbidity and mortality among patients with idiopathic pulmonary fibrosis. However, acute …